Skip to Main Content

Paper Details

Maximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectors.
Elife
25
2022
Author NameAffiliation
Michael E WardNational Institute of Neurological Disorders and Stroke, National Institutes of Health
Luke A GilbertUniversity of California san francisco
Luke A GilbertDepartment of Urology and Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Luke A GilbertArc Institute
Martin KampmannInstitute for Neurodegenerative Disease, University of California san francisco
Martin KampmannUniversity of California san francisco
Jonathan S WeissmanUniversity of California san francisco
Jonathan S WeissmanHoward Hughes Medical Institute, Massachusetts Institute of Technology
Jonathan S WeissmanWhitehead Institute for Biomedical Research
Jonathan S WeissmanMassachusetts Institute of Technology
Jonathan S WeissmanDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
  • 1 - 11

Datasets

Release 1.2